Search results

Filter

Filetype

Your search for "*" yielded 541167 hits

Is there an ‘iron law’ of Big Science?

Big Science is costly and complex, and historical evidence seems to suggest that projects often get delayed and more expensive than planned. On the basis of several studies of large infrastructures such as railroads and bridges, the Danish geographer Bent Flyvbjerg has proposed that there is an “iron law” of megaprojects, meaning that they almost without exception turn out more expensive and more

Big Science and Research Infrastructures in Europe

This thought-provoking book expands on the notion that Big Science is not the only term to describe and investigate particularly large research projects, scientific collaborations and facilities. It investigates the significant overlap between Big Science and Research Infrastructures (RIs) in a European context since the early twenty-first century. Contributions to this innovative book not only au

Daily Adaptive Proton Therapy : Is it Appropriate to Use Analytical Dose Calculations for Plan Adaption?

Purpose: The accuracy of analytical dose calculations (ADC) and dose uncertainties resulting from anatomical changes are both limiting factors in proton therapy. For the latter, rapid plan adaption is necessary; for the former, Monte Carlo (MC) approaches are increasingly recommended. These, however, are inherently slower than analytical approaches, potentially limiting the ability to rapidly adap

Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma

Patients with diffuse large B-cell lymphoma (DLBCL) who fail to complete planned treatment with R-CHOP due to toxicity are sparsely described. We investigated the extent of failure to complete treatment (six cycles or more, or three cycles + RT for patients with stage I disease) with R-CHOP for reasons unrelated to non-response, the determinants of such failure and the outcome among these patients

Comparing Self-Reported Sugar Intake With the Sucrose and Fructose Biomarker From Overnight Urine Samples in Relation to Cardiometabolic Risk Factors

Studies on sugar intake and its link to cardiometabolic risk show inconsistent results, partly due to dietary misreporting. Cost-effective and easily measured nutritional biomarkers that can complement dietary data are warranted. Measurement of 24-h urinary sugars is a biomarker of sugar intake, but there are knowledge gaps regarding the use of overnight urine samples. We aim to compare (1) overni

Persistent identification of instrument

Instruments play an essential role in creating research data. Given the importance of instruments and associated metadata to the assessment of data quality and data reuse, globally unique, persistent and resolvable identification of instruments is crucial. The Research Data Alliance Working Group Persistent Identification of Instruments (PIDINST) developed a community-driven solution for persisten

Alcohol Consumption and Risk of Parkinson's Disease : Data from a Large Prospective European Cohort

Background: Parkinson's disease (PD) etiology is not well understood. Reported inverse associations with smoking and coffee consumption prompted the investigation of alcohol consumption as a risk factor, for which evidence is inconclusive. Objective: To assess the associations between alcohol consumption and PD risk. Methods: Within NeuroEPIC4PD, a prospective European population-based cohort, 694

Climate change impacts on long-term forest productivity might be driven by species turnover rather than by changes in tree growth

Aim: Climate change impacts forest functioning and services through two inter-related effects. First, it impacts tree growth, with effects, for example, on biomass production. Second, climate change also reshuffles community composition, with further effects on forest functioning. However, the relative importance of these two effects has rarely been studied. Here, we developed a new modelling appr

Extracorporeal Membrane Oxygenation Support in Children with Hematological Malignancies in Sweden

Background: Extracorporeal membrane oxygenation (ECMO) is used in severe respiratory and/or circulatory failure when conventional critical care fails. Studies on patients with hematological malignancies on ECMO have shown contradictory results; immunosuppression and coagulopathy are relative contraindications to ECMO. Observations: This nationwide Swedish retrospective chart review identified 958